Jerome Stirnemann
Overview
Explore the profile of Jerome Stirnemann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
154
Citations
1671
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leidi A, Blanc C, Bex S, Porto V, Mazza T, Reinmann M, et al.
Rev Med Suisse
. 2025 Jan;
21(903):172-175.
PMID: 39881640
Through the analysis of notable studies from 2024, this article offers an overview of key advances in internal medicine with a selection of essential themes. The topics covered include advances...
2.
Guffi T, Ehrsam J, Debieux M, Rossel J, Crevier M, Reny J, et al.
BMJ Open
. 2024 Dec;
14(12):e089662.
PMID: 39732480
Introduction: Healthcare practices providing minimal or no benefit to recipients have been estimated to represent 20% of healthcare costs. However, defining, measuring and monitoring low-value care (LVC) and its downstream...
3.
Stirnemann J, Serratrice J, Mann T, Louge P, Christophe C, Samii K, et al.
BMJ Open
. 2024 Nov;
14(11):e084825.
PMID: 39613437
Introduction: Sickle cell disease (SCD) is one of the most common genetic diseases in the world, annually affecting approximately 310 000 births and causing >100 000 deaths. Vaso-occlusive crisis (VOC)...
4.
Mach B, Stirnemann J
Rev Med Suisse
. 2024 Oct;
20(892):1931-1935.
PMID: 39445367
It is common to routinely prescribe gastric ulcer prophylaxis with proton pump inhibitors (PPIs) when administering high-dose glucocorticoids (GC) (> 30 mg/day of prednisone equivalent) or during prolonged time (>...
5.
Jermini M, Fonzo-Christe C, Blondon K, Milaire C, Stirnemann J, Bonnabry P, et al.
Int J Clin Pharm
. 2024 Feb;
46(2):496-505.
PMID: 38315303
Background: Adverse drug events contribute to rising health care costs. Clinical pharmacists can reduce their risks by identifying and solving drug-related problems (DRPs) through medication review. Aim: To develop an...
6.
Hofmeister J, Garin N, Montet X, Scheffler M, Platon A, Poletti P, et al.
Eur Radiol Exp
. 2024 Feb;
8(1):20.
PMID: 38302850
Background: Artificial intelligence (AI) seems promising in diagnosing pneumonia on chest x-rays (CXR), but deep learning (DL) algorithms have primarily been compared with radiologists, whose diagnosis can be not completely...
7.
Carballo S, Agoritsas T, Berner A, Coen M, Darbellay Farhoumand P, Grosgurin O, et al.
Rev Med Suisse
. 2024 Feb;
20(859):214-218.
PMID: 38299949
In this selective overview of articles, we describe new concepts, therapeutic measures and pharmacological agents that may modify current practice in clinical internal medicine. Novelties for the management of cardiovascular...
8.
Befecadu F, Stirnemann J, Guerreiro I, Fusi-Schmidhauser T, Jaksic C, Larkin P, et al.
BMJ Open
. 2023 May;
13(5):e068340.
PMID: 37173103
Introduction: Chronic obstructive pulmonary disease (COPD) is responsible for 2.9 million deaths annually in Europe. Symptom burden and functional decline rise as patients reach advanced stages of the disease enhancing...
9.
John G, Arcens M, Berra G, Garin N, Carballo D, Carballo S, et al.
BMJ Open
. 2023 May;
12(8):e053632.
PMID: 37129085
Objectives: Patients with acute congestive heart failure (HF) regularly undergo urinary catheterisation (UC) at hospital admission. We hypothesised that UC has no clinical benefits with regard to weight loss during...
10.
Marti C, Gaudet-Blavignac C, Martin J, Lovis C, Stirnemann J, Grosgurin O, et al.
Sci Rep
. 2023 Apr;
13(1):6013.
PMID: 37045983
Two successive COVID-19 flares occurred in Switzerland in spring and autumn 2020. During these periods, therapeutic strategies have been constantly adapted based on emerging evidence. We aimed to describe these...